8-K//Current report
Jounce Therapeutics, Inc. 8-K
Accession 0001640455-23-000045
CIK 0001640455operating
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:08 PM ET
Size
155.8 KB
Accession
0001640455-23-000045
Documents
- 8-Kjnce-20230326.htmPrimary
8-K
- EX-101.SCHjnce-20230326.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABjnce-20230326_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREjnce-20230326_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLjnce-20230326_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001640455-23-000045-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001640455
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:08 PM ET
- Size
- 155.8 KB